Medical news of Remedium.ru portal is the most update information on pharmaceutical and medical equipment market

Journals

REMEDIUM

The periodical about the pharmaceutical and medical equipment markets

ROSSIYSKIE APTEKI

(Russian pharmacies) - specialized periodical edition for pgarmacy professionals

MEDITSINSKY SOVET

Medical Council - Scientific Journal for Physicians


Home / News

14.02.2007

Scrip Pharmaceuticals, 13.02.07, Russia’s retail pharma market grows by 30% in 2006

The pharmacy sector of Russian pharmaceutical market grew by 29% to $6.6 billion, but the number of packs sold increased by only 3% to 3.7 billion packs, says RMBC, the Moscow-based market research company. The calculations exclude supplies under the restricted reimbursement programme (Scrip No 3001, p 3).

Foreign manufacturers continue to prevail on the market, and their share in pharmacy sales increased by 0.9 percentage points to 77.2%.

RMBC said that the average retail price of a pack of medicines increased by 26% to $1.8 and per capita consumption rose by 30% to $46.2. The shares of prescription and OTC products in sales were very close to each other by value _ 54% and 46% respectively.

Generic drugs accounted for more than 70% of total sales and average prices were $2.2 and $1.0 per pack of prescription and OTC products.

However, the growth rate of sales of generics was lower that that of innovative medicines _ 26% and 34% respectively. The average price of a pack of innovative prescription drug increased by 11% to $12.5, and that of an innovative OTC product was $5.5 (+13%).

There were no changes in top six companies _ Novartis was ranked first, with a 6.2% share in pharmacy sales, followed by Sanofi-Aventis (4.9%), Servier/Egis (4.6%), Berlin-Chemie/Menarini Group (3.7%), Pfizer (3.1%) and Gedeon Richter (2.8%).

In contrast, the RMBC’s rating of top selling medicines has changed in comparison with 2005 _ the domestic anti-viral product Arbidol raised from the sixth position to the first, with a 1.1% sales share. It was followed by Pfizer’s Viagra (sildenafil citrate) and traditional Russia’s favourites, such as Essentialle, a combination of phospholipids, Actovegin, an extract of calf blood, and Mesim Forte, a mixture of pancreatic enzymes.

In terms of therapeutic categories, anti-infectives led the RMBC’s list, with a 6.1% share in pharmacy sales, followed by analgesics (5.8%) and pharmaceuticals modulating immune response (4.3%).


Source:  Scrip Pharmaceuticals

Remedium group

REMEDIUM

publishing house

CLIFAR

programmer of electronic software products

R-PRESS

advertisement agency

REPRENT

rent-a-rep company